Fibric Acid Derivatives

Alona Crowder, PharmD, Simeon Margolis, M.D.
Fibric Acid Derivatives is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Primary hypercholesterolemia or mixed dyslipidemia: To reduce LDL, total cholesterol, and triglycerides.
    • Of note, this class of medications has not shown a reduction in coronary heart disease morbidity and mortality in large, randomized controlled trials of patients with type 2 diabetes mellitus.[1][2]
  • Hypertriglyceridemia: Adjunct to diet treatment and improved glycemic control in patients with diabetes.

NON-FDA APPROVED USES

  • Prevention of acute pancreatitis secondary to severe hypertriglyceridemia

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 7, 2018

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Fibric Acid Derivatives ID - 547053 A1 - Crowder,Alona,PharmD AU - Margolis,Simeon,M.D. Y1 - 2018/01/07/ PB - Johns Hopkins Diabetes Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives ER -